SCHEMBL4886560

SCHEMBL4886560

CCOc1cc(B(c2cc(OCC)c(F)cc2F)c2cc(OCC)c(F)cc2F)c(F)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.39
HTT P42858 2/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
TUBB1 Q9H4B7 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
LMNA P02545 2/20 0.34
ALDH1A1 P00352 6/20 0.33
POLB P06746 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2916070 0.86 KDM1A (0.38) KDM1AHTTL3MBTL1TUBB1PDE4A
SCHEMBL29953693 0.78 KDM1A (0.38) KDM1AHTTL3MBTL1TUBB1PDE4A
SCHEMBL30464897 0.77 RAB9A (0.37) KDM1AHTTTUBB1LMNAALDH1A1
SCHEMBL4891306 0.77 RAB9A (0.37) KDM1AHTTTUBB1LMNAALDH1A1
SCHEMBL18304662 0.75 KDM1A (0.41) KDM1AHTTL3MBTL1TUBB1LMNA
SCHEMBL8263925 0.73 TUBB1 (0.41) KDM1AHTTL3MBTL1TUBB1PDE4A
SCHEMBL17543319 0.73 MAPT (0.47) KDM1AHTTL3MBTL1TUBB1PDE4A
SCHEMBL2916640 0.73 LMNA (0.47) KDM1AHTTL3MBTL1TUBB1LMNA
SCHEMBL19088272 0.73 KDM1A (0.40) KDM1AHTTL3MBTL1TUBB1LMNA
SCHEMBL24755215 0.72 KDM1A (0.42) KDM1AHTTL3MBTL1TUBB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817318-B1 STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS NIPPON CATALYTIC CHEM IND (JP) 2013-08-28 EP disclosed
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds NIPPON SHOKUBAI CO., LTD. (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds AR, AHR, BCL6 KDM1A 476/4885HTT 445/4885L3MBTL1 2660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.